Why Rocket Companies Inc. (RKT) Skyrocketed On Monday?

We recently published a list of Biotech Stocks Dominate Monday’s Top 10 Gainers. In this article, we are going to take a look at where Rocket Companies Inc. (NYSE:RKT) stands against other biotech stocks that dominate Monday’s top gainers.

The stock market kicked off the shortened trading week on a positive note, with Wall Street’s major indices finishing in the green following President Donald Trump’s temporary tax reprieve on technology companies.

The S&P 500 recorded the highest gain, up 0.79 percent, while the Dow Jones came second at 0.78 percent. The tech-heavy Nasdaq was also up by 0.64 percent.

Benchmark indices aside, 10 companies dominated by biotechnology firms mirrored the broader market optimism, recording modest gains during the session.

In this article, let us explore Monday’s top 10 gainers and the reasons behind their gains.

To come up with the list, we only considered the stocks with $2 billion market capitalization and $5 million trading volume.

A businessperson using a laptop to review the details of a mortgage loan for a client.

Rocket Companies Inc. (NYSE:RKT)

Rocket Companies rose for a second day on Monday, adding 7.98 percent to end at $12.85 apiece, riding an overall market optimism while continuing to digest its recent shopping spree of its counterparts.

Earlier this month, RKT announced that it would acquire home loan provider Mr. Cooper (NASDAQ:COOP) for $9.4 billion in a bid to accelerate its AI-powered platform and remove the friction and complexities plaguing today’s homebuying process.

“Servicing is a critical pillar of homeownership—alongside home search and mortgage origination. With the right data and AI infrastructure, we will deliver the right products at the right time. That’s how we build lifelong relationships, by proactively unlocking benefits and meeting needs before they arise. We look forward to welcoming Mr. Cooper’s nearly 7 million clients,” said RKT CEO Varun Krishna.

Last month, RKT also announced its acquisition of Redfin (NASDAQ:RDFN) for $1.75 billion. The transaction involved the buyout of shares at a price of $12.50 apiece.

Founded in 2004, RDFN is one of America’s most recognized real estate brands, operating a top-three home search platform with more than 1 million for-sale and rental listings and a tech-powered brokerage of more than 2,200 agents.

Overall, RKT ranks 8th on our list of biotech stocks that dominate Monday’s top gainers. While we acknowledge the potential of RKT as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than RKT but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.